-
1Dissertation/ Thesis
Συγγραφείς: Camargo Ariza, William Alejandro
Συνεισφορές: Varela Ramírez, Rodolfo, Castañeda Millán, David Andrés, Grupo de Investigación e Innovación en Urología Universidad Nacional de Colombia, Camargo Ariza, William A [0000-0002-0446-1248]
Θεματικοί όροι: Vacuna BCG, Administración intravesical, Barriers to access of health services, 617 - Cirugía, medicina regional, odontología, oftalmología, otología, audiología [610 - Medicina y salud], Urinary bladder neoplasms, Neoplasias vesicales sin invasión muscular, Administración Intravesical, 616 - Enfermedades [610 - Medicina y salud], Immunotherapy - Statistics & numerical data, Administration, intravesical, BCG Vaccine, Inmunoterapia - Estadística & datos numéricos, Inmunoterapia, Neoplasias de la vejiga urinaria, Intravesical Drug Administration, Non-Muscle Invasive Bladder Neoplasms, Barreras de acceso a los servicios de salud
Περιγραφή αρχείου: 20 páginas; application/pdf
Σύνδεσμος πρόσβασης: https://repositorio.unal.edu.co/handle/unal/85593
-
2Dissertation/ Thesis
Συγγραφείς: Camargo Ariza, William Alejandro
Συνεισφορές: Varela Ramírez, Rodolfo, Castañeda Millán, David Andrés, Grupo de Investigación e Innovación en Urología Universidad Nacional de Colombia, Camargo Ariza, William A 0000-0002-0446-1248
Θεματικοί όροι: 610 - Medicina y salud::617 - Cirugía, medicina regional, odontología, oftalmología, otología, audiología, 610 - Medicina y salud::616 - Enfermedades, Vacuna BCG, Inmunoterapia - Estadística & datos numéricos, Neoplasias de la vejiga urinaria, Barreras de acceso a los servicios de salud, Administración intravesical, BCG Vaccine, Immunotherapy - Statistics & numerical data, Urinary bladder neoplasms, Barriers to access of health services, Administration, intravesical, Neoplasias vesicales sin invasión muscular, Inmunoterapia, Non-Muscle Invasive Bladder Neoplasms, Intravesical Drug Administration
Περιγραφή αρχείου: 20 páginas; application/pdf
Relation: IARC, Cancer Today. Estimated number of new cases in 2020, worldwide, both sexes, all ages. 2021. 2022.; Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, La Vecchia C, Shariat S, Lotan Y. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63(2):234–41.; Lenis AT, Lec PM, Chamie K, Mshs MD. Bladder Cancer: A Review. JAMA. 2020 Nov 17;324(19):1980-1991; Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249; Sylvester RJ, van der MEIJDEN AP, Lamm DL. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol. 2002 Nov;168(5):1964-70; Aghamir SMK, Khatami F, Farrokhpour H, Oliveira Reis L, Ahmadi Pishkuhi M, Mohammadi A (2022) Oncologic outcomes of Bacillus Calmette-Guérin therapy in elderly patients with non-muscle-invasive bladder cancer: A meta-analysis. PLoS ONE 17(5): e0267934.; EAU Guidelines. Non-muscle-invasive Bladder Cancer. Presented at the EAU Annual Congress Milan 2023. ISBN 978-94-92671-19-6.; Krajewski W. Urothelial carcinoma working group. Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomes. World J Urol. 2021 Jul;39(7):2545-2552. doi:10.1007/s00345-020-03522-3; Subiela JD, Rodríguez Faba Ó, Aumatell J, Calderón J, Mercadé A, Balañà J, Esquinas C, Algaba F, Breda A, Palou J. Contemporary outcomes of bladder carcinoma in situ treated with an adequate bacille Calmette-Guérin immunotherapy. BJU Int. 2022 Apr;129(4):542-550. doi:10.1111/bju.15567.; Morales A. BCG: A throwback from the stone age of vaccines opened the path for bladder cancer immunotherapy. Can J Urol. 2017 Jun;24(3):8788-8793.; Herr HW, Morales A. History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story. J Urol. 2008 Jan;179(1):53-6. doi:10.1016/j.juro.2007.08.122.; Van der Meijden AP, Sylvester RJ, Oosterlinck W, Hoeltl W, Bono AV; EORTC Genito-Urinary Tract Cancer Group. Maintenance Bacillus Calmette-Guerin for Ta T1 bladder tumors is not associated with increased toxicity: results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial. Eur Urol. 2003 Oct;44(4):429-34. doi:10.1016/s0302-2838(03)00357-9.; Calò B, Falagario U, Sanguedolce F, Veccia A, Chirico M, Carvalho-Diaz E, Mota P, Lima E, Autorino R, Carrieri G, Cormio L. Impact of time to second transurethral resection on oncological outcomes of patients with high-grade T1 bladder cancer treated with intravesical Bacillus Calmette-Guerin. World J Urol. 2020 Dec;38(12):3161-3167. doi:10.1007/s00345-020-03108-z.; Hensley PJ, Bree KK, Brooks N, Matulay J, Li R, Nogueras González GM, Navai N, Grossman HB, Dinney CP, Kamat AM. Time interval from transurethral resection of bladder tumour to bacille Calmette-Guérin induction does not impact therapeutic response. BJU Int. 2021 Nov;128(5):634-641.; Cernuschi T, Malvolti S, Nickels E, Friede M. Bacillus Calmette-Guérin (BCG) vaccine: a global assessment of demand and supply balance. Vaccine. 2018;36(4):498–506. doi:10.1016/j.vaccine.2017.12.010; Davies BJ, Hwang TJ, Kesselheim AS. Ensuring access to injectable generic drugs - The case of intravesical BCG for bladder cancer. N Engl J Med. 2017;376(15):1401–1403. doi:10.1056/NEJMp1615697; Guallar-Garrido S, Julián E. Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update. Immunotargets Ther. 2020 Feb 13;9:1-11. doi:10.2147/ITT.S202006; Ourfali S, Ohannessian R, Fassi-Fehri H, Pages A, Badet L, Colombel M. Recurrence Rate and Cost Consequence of the Shortage of Bacillus Calmette-Guérin Connaught Strain for Bladder Cancer Patients. Eur Urol Focus. 2021 Jan;7(1):111-116. doi:10.1016/j.euf.2019.04.002; Paniz VM, Fassa AG, Maia MF, Domingues MR, Bertoldi AD. Measuring access to medicines: a review of quantitative methods used in household surveys. BMC Health Serv Res. 2010 May 30;10:146. doi:10.1186/1472-6963-10-146.; https://repositorio.unal.edu.co/handle/unal/85593; Universidad Nacional de Colombia; Repositorio Institucional Universidad Nacional de Colombia; https://repositorio.unal.edu.co/